NASDAQ · Analyst Forecast

LifeStance Health Group, Inc. (LFST) Stock Forecast & Price Target

$14.17 NASDAQ: LFST Market Cap $5.39B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering LifeStance Health Group, Inc. (LFST), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For LifeStance Health Group, Inc., analysts forecast revenue rising from $1.04B in 2023 to $2.28B in 2028; the average estimate for 2028 earnings per share is $0.45; with published estimates ranging from $0.40 to $0.50; 9 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$14.17
Consensus targetThe average of the price targets analysts have published.$14.14
Median targetThe middle target, less affected by a single outlier.$15.00
Highest targetThe most optimistic published target.$19.00
Lowest targetThe most pessimistic published target.$9.00
Difference from priceHow far the consensus target sits from today’s price.-0.2%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2023$1.03B$1.04B$1.05B6
2024$1.21B$1.24B$1.26B4
2025$1.39B$1.42B$1.44B6
2026$1.72B$1.75B$1.77B8
2027$1.95B$1.98B$2.03B8
2028$2.22B$2.28B$2.33B9

Earnings per share forecast

YearLowAverageHighAnalysts
2023−$0.49−$0.48−$0.466
2024−$0.17−$0.17−$0.164
2025−$0.00−$0.00−$0.006
2026$0.19$0.20$0.228
2027$0.23$0.24$0.258
2028$0.40$0.45$0.509

LifeStance Health Group, Inc. (LFST) forecast — frequently asked questions

What is the analyst price target for LifeStance Health Group, Inc.?

Analysts covering LifeStance Health Group, Inc. (LFST) have a consensus price target of $14.14, 0.2% below the current price of $14.17. Published targets range from $9.00 to $19.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for LifeStance Health Group, Inc.'s earnings?

The average analyst estimate for LifeStance Health Group, Inc. (LFST) earnings per share in 2028 is 0.45, with individual estimates between 0.40 and 0.50.

How much revenue is LifeStance Health Group, Inc. expected to make?

Analysts forecast LifeStance Health Group, Inc. (LFST) revenue of $2.28B in 2028, based on 9 published estimates.

How many analysts cover LFST?

9 analysts contribute estimates for LifeStance Health Group, Inc. (LFST). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Care Facilities stocks

HCA forecastTHC forecastEHC forecastDVA forecastENSG forecastUHS forecastCHE forecastOPCH forecastHIMS forecastACHC forecastAll Medical - Care Facilities stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.